Adolescent Meningococcal Vaccines: Impact and Potential Changes

This Event has Passed

Where

Virtual

When

{{getUserDateTimezone("1721840400").singleDate}}
{{getUserDateTimezone("1721840400").time}} - {{getUserDateTimezone("1721842200").time}} {{getClientTimezoneName()}}

About

Invasive meningococcal disease (IMD) is rare but devastating. The CDC’s Advisory Committee on Immunization Practices (ACIP) is considering changes to the adolescent meningococcal vaccination schedule that could impact immunization policies. STAT Brand Studio discusses these potential revisions with Richard H. Hughes IV, Will Humble, and Leslie Maier, exploring the importance of school vaccination requirements and potential effects of schedule changes on public health and equity.

Moderator

Jesse McQuarters, Branded Content Editor at STAT

Speakers

Richard H. Hughes IV, JD, MPH, Partner at Epstein, Becker & Green

Richard H. Hughes IV, JD, MPH, is a partner at Epstein, Becker & Green and a professorial lecturer in law at The George Washington University Law School and a nationally recognized vaccine thought leader who has led many efforts to expand access to vaccines and preventive services and improve public health outcomes.

Will Humble, Executive Director, Arizona Public Health Association

Will Humble is the Executive Director for the Arizona Public Health Association. His 35 years in public health included more than 2 decades at the Arizona Department of Health Services, where he served in various capacities including as the Agency Director from 2009 to 2015.

Leslie Maier, Advocate

Leslie Maier lost her son Chris, a high school senior who died from meningococcal disease at age 17. Leslie has been a fierce advocate for meningitis awareness and prevention. Her accomplishments include working with the Arizona Department of Health to make Arizona the first state to mandate vaccination for 11-12-year-olds.